Webinar replay

Behind the Scenes of a Billion Dollar Pharma Deal

On 9 June 2020 Eli Lilly and Evox Therapeutics inked a neuroscience therapy deal worth $1.2 billion.

In this webinar two of the key players in that deal will take you behind-the-scenes to explain how Evox got on Lilly’s radar, explore the challenges of forming a partnership under a COVID-19 lockdown, and recall the discussions and internal debates that led to one of the biggest biopharma deals of the year so far.

Go behind the scenes with:
Raymond Jordt
Vice President of Corporate Business Development
Eli Lilly
Simon Dew
Vice President of Business Development
Evox Therapeutics

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates the find, deal, and collaborate phases of biopharma partnering. Its market-leading platform is used by 60% of the world’s top 50 pharma companies to source and manage their opportunities efficiently, and its technology powers more than 50,000 partnering meetings each year at the world's most important biopharma partnering conferences, including the BIO International Convention.
With subsidiaries Labiotech and IN-PART, Inova reaches more than 100,000 readers in life sciences a month and connects a network of 6,500 industry players and academic organizations.